When we focused on intermediate-risk nephroblastoma, the median blastemal Ki-67 SI was 61% (range, 60%–91%) for cases with metastases (n = 8) whereas it was 25% (range, 3%–69%) for cases without metastasis (n = 33). Here, MKI67 is linked to Wilms tumor.